Mary Gleeson^1*, Eliza A Hawkes^1*, David Cunningham^1*, Nick Chadwick^2*, Nick Counsell^2*, Anthony Lawrie^2*, Andrew Jack^3*, Paul Smith^2*, Paul Mouncey^2*, Christopher Pocock⁴, Kirit Ardeshna^5,6*, John Radford^7*, Andrew McMillan^8*, John Davies^9*, Deborah Turner^10*, Anton Kruger^11*, Peter W.M. Johnson, FRCP^12*, Joanna Gambell^2* and David Linch^5*

¹The Royal Marsden Hospital, London and Surrey, United Kingdom
²Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom
³HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁴East Kent Hospitals, Canterbury, United Kingdom
⁵University College London, London, United Kingdom
⁶Mount Vernon Cancer Centre, Northwood, United Kingdom
⁷The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
⁸Nottingham City Hospital, Nottingham, United Kingdom
⁹Western General Hospital, Edinburgh, United Kingdom
¹⁰Torbay Hospital, Torquay, United Kingdom
¹¹Royal Cornwall Hospital, Truro, United Kingdom
¹²Cancer Research UK Centre, Southampton, United Kingdom

Tongyu Lin^*, He Huang^*, Xueying Li^*, Chengcheng Guo^*, Huangming Hong^*, Xiaohong Fu^*, Xiaoting Lin^*, Xiaojie Fang^*, Zhao Wang^* and Zhongjun Xia, MD

Sun Yat-sen University Cancer Center, Guangzhou, China

Jacob D Soumerai, MD¹, Andrew D Zelenetz, MD, PhD¹, Craig H Moskowitz, MD², Anas Younes, MD¹, Maria Lia Palomba, MD¹, Paul A Hamlin Jr., MD¹, Ariela Noy, MD¹, Steven M Horwitz, MD¹, Matthew J. Matasar, MD, MS², Alison J Moskowitz, MD¹, Carol S Portlock, MD¹, David J Straus, MD¹, Alice Chen, MD^3*, Richard F Little, MD, MPH³, Fallon France^4*, Juho Whang^4*, Nishant Mishra^4*, Christine Jarjies^4* and John F Gerecitano, MD, PhD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY
³Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD
⁴Memorial Sloan Kettering Cancer Center, New York, NY

Jaleh Fallah, MD¹, Anthony G Thomas, DO, FACP^1,2* and Adam J Olszewski, MD^1,2

¹Department of Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI
²Division of Hematology-Oncology, Alpert Medical School of Brown University, Providence, RI

Adam M. Petrich, MD¹, Leo I. Gordon, MD², Jeffrey R. Infante, MD^3*, Sumit Madan, MD^4*, Francis J. Giles, MD^5*, Halla S. Nimeiri, MBBS^1*, Jason B. Kaplan, MD^1*, Kate Stumpo^6*, Bin Zhang, ScD^7*, Stephanie Faucette, PharmD, PhD^8*, Yaping Shou, MD, PhD^9* and Kent C. Shih, MD^10*

¹NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University, Chicago, IL
²Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
³Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁴Hematology-Oncology, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, TX
⁵NMDTI, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago
⁶Clinical Operations Early Development, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁷Global Statistics, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁸Clinical Pharmacology, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁹Oncology Clinical Research, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
¹⁰Neuro-Oncology Program, Sarah Cannon Research Institute, Nashville, TN

Jakub Svoboda, MD¹, Lauren E. Strelec, BA^1*, Sunita Dwivedy Nasta, MD^1*, Daniel J. Landsburg, MD¹, Anthony R. Mato, MD^2*, Barbara Pro³, Stefan Klaus Barta, MD, MRCP, MS⁴, Nirav N. Shah, MD¹, Sarah Jordan Nagle, MD^1*, Elise A. Chong, MD¹, Ellen Napier, NP^1*, Samantha Garrett^1* and Stephen J. Schuster, MD¹

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Center for Chronic Lymphocytic Leukemia, University of Pennsylvania, Philadelphia, PA
³Thomas Jefferson University, Philadelphia, PA
⁴Fox Chase Cancer Center, Philadelphia, PA

Kristin C. Marr, MD^1*, Joseph M. Connors, MD², Karen J. Goddard, MD^3*, Kerry J. Savage, MD MSc² and Rebecca J. Deyell, MD^1*

¹Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, British Columbia Children’s Hospital, University of British Columbia, Vancouver, BC, Canada, Vancouver, BC, Canada
²British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
³British Columbia Cancer Agency, Department of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada, Vancouver, BC, Canada

Daniel J. Landsburg, MD¹, Marissa K. Falkiewicz^2*, Jennifer J.D. Morrissette, PhD^3*, April M. Schrank-Hacker^4*, Sunita Dwivedy Nasta, MD⁵, Jakub Svoboda, MD⁶, Stephen J. Schuster, MD⁷, Anthony R. Mato, MD^8*, Benjamin A. Chu^9*, Yanming Zhang, MD¹⁰, Amir Behdad, MD^10* and Adam M. Petrich, MD¹¹

¹Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Robert Wood Johnson Medical School, New Brunswick, NJ
³Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
⁴Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Lymphoma Program, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁷Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
⁸Center for Chronic Lymphocytic Leukemia, University of Pennsylvania, Philadelphia, PA
⁹Feinberg School of Medicine, Northwestern University, Chicago, IL
¹⁰Department of Pathology, Northwestern University, Chicago, IL
¹¹Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL

Simonetta Viviani, MD^1*, Alberto Mussetti, MD^1*, Oreste Di Bartolo, MD^2*, Antonello Cabras, MD^3*, Pinuccia Valagussa, Statistician^4*, Gianni Bonadonna, MD^4*, Alessandro M. Gianni, MD⁵ and Paolo Corradini, MD⁶

¹Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
²Chair of Hematology, Università degli Studi, Catania, Italy
³Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁴Fondazione Michelangelo, Milan, Italy
⁵Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
⁶Department of Hematology and Pediatric Onco-Hematology, Fondazione IRCCS Istituto Nazionale Tumori and University of Milano, Milan, Italy

Eldad J Dann, MD^1,2, Vered Heffes, BsC^1*, Tatiana Mashiach, MSc^2*, Noam Benyamini, MD^3*, Irit Avivi, MD^4* and Netanel A Horowitz, MD^1,2*

¹Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
²Rambam Health Care Campus, Haifa, Israel
³Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
⁴R, Haifa, Israel

Pau Abrisqueta, MD^1*, Graham W Slack, MD^1*, David W Scott, MBChB, PhD¹, Randy D. Gascoyne², Joseph M. Connors, MD³, Laurie H. Sehn¹, Kerry J. Savage, MD MSc³ and Diego Villa, MD, MPH⁴

¹Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
²British Columbia Cancer Agency, Centre for Lymphoid Cancer, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada
³British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
⁴BC Cancer Agency and University of British Columbia, Centre for Lymphoid Cancer, Vancouver, BC, Canada

Preetesh Jain, MBBS, MD, DM, PhD^1*, Keyur P. Patel, MD, PhD^2*, Andrew Futreal, PhD^3*, Curtis Gumbs^3*, Shimin Hu, PhD, MD^4*, Carlos Bueso Ramos, MD^5*, Michael Wang, MD⁶, Jorge Romaguera^5*, Luis E. Fayad, MD⁷, Robert Z. Orlowski, Ph.D., M.D.⁷, Jeffrey Medeiros^5* and Nathan Fowler, MD⁸

¹Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴University of Texas MD Anderson Cancer Center PTH Program, Houston, TX
⁵University of Texas, The MD Anderson Cancer Center, Houston
⁶Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Sarah Jordan Nagle, MD^1*, Nirav N. Shah, MD¹, Alex Ganetsky, PharmD, BCOP^2*, Daniel J. Landsburg, MD¹, Sunita Dwivedy Nasta, MD¹, Anthony Mato, MD^1*, Stephen J. Schuster, MD¹, Donald Edward Tsai, MD, PhD¹ and Jakub Svoboda, MD³

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA
³Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Mitchell R. Smith, MD, PhD¹, Hailun Li, PhD^2*, Fangxin Hong, Ph.D.³, Leo I. Gordon, MD⁴, Randy D. Gascoyne⁵, Elisabeth Paietta, MD⁶, Ranjana H Advani, MD⁷, Andres Forrero-Torres^8*, Sandra J Horning, MD⁹ and Brad S. Kahl, MD¹⁰

¹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²ECOG-ACRIN, Boston, MA
³Harvard School of Public Health, Boston, MA
⁴Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
⁵Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
⁶Cancer Center, Montefiore Medical Center North Division, Bronx, NY
⁷Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, CA
⁸University of Alabama-Birmingham, Birmingham, AL
⁹Genentech, Inc., South San Francisco, CA
¹⁰Department of Medicine-Hematology/Oncology, University of Wisconsin, Madison, WI

Masahito Tokunaga, M.D.^1*, Kentaro Yonekura^2*, Daisuke Nakamura^3*, Kouichi Haraguchi^4*, Tomohisa Tabuchi^5*, Nobuaki Nakano^1*, Ayumu Kubota, M.D.^1*, Shogo Takeuchi, M.D.^1*, Yoshifusa Takatsuka^1*, Makoto Yoshimitsu⁵, Satoshi Fujino^5*, Maiko Hayashida^5*, Kenichi Maekawa^5*, Akihiko Arai^4*, Yuhei Kamata^5*, Hirosaka Inoue^5*, Satsuki Owatari^4*, Maki Otsuka^4*, Shuichi Hanada⁴, Tadashi Matsumoto^3* and Atae Utsunomiya, M.D., Ph.D.¹

¹Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
²Department of Dermatology, Imamura Bun-in Hospital, Kagoshima, Japan
³Department of Hematology, Imamura Hospital, Kagoshima, Japan
⁴Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan
⁵Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan

Anita K. Gandhi, PhD^1*, Ribrag Vincent, MD^2*, Cecilia Carpio, MD^3*, Anne-Marie Stoppa, MD⁴, Mecide Meric Gharibo, MD^5*, Sylvia Damian, MD^6*, Drew W Rasco, MD^7*, Loïc Ysebaert, MD PhD^8*, Raúl Cordoba, MD^9*, Armando Santoro, MD^10*, William J Edenfield, MD^11*, Antonio Pinto^12*, José Antonio López-Martín, MD^13*, Juan Manuel Sancho, MD, PhD^14*, Carlos Panizo, PhD^15*, Xin Wei^1*, Patrick Hagner, PhD^1*, Michelle Waldman, MS^1*, Kristen Hege¹⁶, Rajesh Chopra, MBBS, PhD¹ and Michael Pourdehnad, MD^16*

¹Celgene Corporation, Summit, NJ
²Service d'Hématologie, Institut Gustave Roussy, Villejuif, France
³Hospital Vall d'Hebron, Barcelona, Spain
⁴Institut Paoli Calmettes, Marseille, France
⁵Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁶Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
⁷START, San Antonio, TX
⁸Département d'Hématologie, IUCT-Oncopole, Toulouse, France
⁹Hospital Fundación Jiménez-Díaz, Madrid, Spain
¹⁰Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy
¹¹Cancer Centers Of The Carolinas, Greenville, SC
¹²Fondazione ‘G.Pascale’, IRCCS, Istituto Nazionale Tumori, Naples, Italy
¹³12 de Octubre University Hospital, Madrid, Spain
¹⁴Clinica Universidad de Navarra, Pamplona, Spain
¹⁵Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
¹⁶Celgene Corporation, San Francisco, CA

Michelle A. Fanale, MD¹, Zhiqiang Wang, PhD^1*, Wencai Ma, PhD^1*, Yasuhiro Oki, MD¹, Fredrick B. Hagemeister, MD¹, Luis E. Fayad, MD¹, Nathan Fowler, MD¹, Jorge E. Romaguera, MD¹, Nina Shah, MD², Hubert H Chuang, MD, PhD^3*, Feng Lei, MS^4*, Sandra B. Horowitz, PharmD^5*, Dai Chihara, MD, PhD¹, Emily Wesson, APN^1*, Toni Y Hutto, BS^1*, Charnelle Ruben, BS^1*, Felipe Samaniego, MD¹, Tariq Muzzafar, MD⁶, Richard Piekarz, PhD, MD^7* and R Eric Davis, MD^1*

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Cancer Therapeutics Evaluation Program, National Institute of Health, Bethesda, MD

Nathan Fowler, MD¹, Thomas E Boyd, MD^2*, Jeff P. Sharman, MD³, Sonali M. Smith, MD⁴, Fong Clow, ScD⁵, Alvina D. Chu, MD^5* and Ranjana H Advani, MD⁶

¹Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
²Oncology/Hematology, Yakima Valley Memorial Hospital/North Star Lodge Cancer Center, Yakima, WA
³Willamette Valley Cancer Institute, Springfield, OR
⁴University of Chicago, Chicago, IL
⁵Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
⁶Oncology, Department of Internal Medicine, Stanford University Medical Center, Stanford, CA

Pieternella J Lugtenburg, MD, PhD¹, Josée M Zijlstra, MD, PhD^2*, Jeanette K Doorduijn, MD, PhD¹, Lara H Böhmer, MD^3*, Marinus van Marwijk Kooy, MD, PhD^4*, Mels Hoogendoorn, MD, PhD^5*, Henriette W Berenschot, MD^6*, Aart Beeker, MD⁷, Fransje Valster, MD^8*, Harry C. Schouten⁹, Marleen Luten, MSc^10*, Henk Hofwegen^10*, Dana A Chitu, PhD^11*, Rolf E Brouwer, MD, PhD¹² and Gustaaf W van Imhoff, MD, PhD¹³

¹Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
²Department of Hematology, VU University Medical Center Amsterdam, Amsterdam, Netherlands
³Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
⁴Department of Internal Medicine, Isala Clinic, Zwolle, Netherlands
⁵Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands
⁶Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
⁷Department of Internal Medicine, Spaarne Hospital, Hoofddorp, Netherlands
⁸Department of Internal Medicine, Bravis Hospital, Bergen op Zoom, Netherlands
⁹Department of Internal Medicine - Hematology, Maastricht University Medical Center, Maastricht, Netherlands
¹⁰HOVON Data Center, Clinical Trial Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹¹HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹²Department of Internal Medicine, Reinier de Graaf Group, Delft, Netherlands
¹³Department of Hematology, University Hospital Groningen, Groningen, Netherlands

Olga A. Gavrilina, MD^1*, Eugene E. Zvonkov, MD, PhD^2*, Elena N. Parovichnikova, MD, PhD^2*, Vera V. Troitskaya, MD, PhD^2*, Nelly G. Gabeeva, PhD^3*, Andrey V. Gubkin^4*, Larisa A. Kuzmina, MD, PhD^5*, Valery A. Lapin^6*, Inessa Yu. Toropova^6*, Vitalii S. Kanin^7* and Valeri G. Savchenko, MD, PhD, Prof.²

¹National Research Center For Hematology, Moscow, Russia
²National Research Center for Hematology, Moscow, Russia
³Department Chemotherapy of lymphomas, National Research Center for Hematology, Moscow, Russia
⁴Central Clinical Hospital №2, Moscow, Russia
⁵Department of BMT, National Research Center for Hematology, Moscow, Russia
⁶Yaroslavl Regional Hospital, Yaroslavl, Russia
⁷Regional Clinical Center of Oncology, Khabarovsk, Russia

Wei-Li Ma, MD

Oncology, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan

Antonio Branca, MD^1*, Ilaria Gianesello, MD^2*, Luca Brugnaro, RN^3*, Tamara Berno, MD^2*, Silvia Imbergamo, MD^2*, Federica Lessi, MD^2*, Kety Sammartin, MD^2*, Fabrizio Vianello, MD^2*, Fausto Adami, MD^2*, Gianni Binotto^2*, Carmela Gurrieri, MD^2*, Livio Trentin, MD², Carlo Visco, MD^4*, Renato Zambello^2*, Francesco Piazza, MD⁵ and Gianpietro Semenzato^2*

¹Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy
²Department of Medicine, Hematology and Clinical Immunology Section, University of Padova, Padova, Italy
³Padova University Hospital, Padova, Italy
⁴Department of Hematology and Cell Therapy, Ospedale San Bortolo, Vicenza, Italy
⁵Department of Medicine, Hematology and Clinical Immunology Section, University of Padova and Venetian Institute of Molecular Medicine, Padova, Italy

Binod Dhakal, MD¹, Sridevi Ramalingam, MD^2*, Jamie Shuff, MD^3*, Narendranath Epperla, MD⁴, Lisa Rein, MS^5*, Anjishnu Banerjee, PhD^6*, Malika Siker, MD^7*, Paul R. Hosking, MD^5*, Parameswaran Hari, MD, MRCP, MS⁵, Anita D'Souza, MBBS, MD⁸, Ehab Atallah, MD⁹, Beth Erisckson, MD^7*, Timothy S. Fenske, MD⁴ and Mehdi Hamadani, M.D.^10*

¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²Medical College of Wisconsin, milwaukee, WI
³Radiation Oncology Associates, Reno, NV
⁴Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Department of Biostatistics, Medical College of Wisconsin, Milwaukee, WI
⁷Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
⁸Froedtert Memorial Lutheran Hospital, Milwaukee, WI
⁹Department of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
¹⁰Dept. of Medicine, Medical College of Wisconsin, Milwaukee, WI

Lalita Norasetthada, MD¹, Weerasak Nawarawong, MD², Arnuparp Lekhakula, MD, MS^3*, Jakrawadee Julamanee, MD^3*, Chittima Sirijerachai, MD^4*, Kanchana Chansung, MD^4*, Kitsada Wudhikarn, MD^5*, Udomsak Bunworasate, MD^6*, Noppadol Siritanaratanakul, MD⁷, Archrob Khuhapinant, MD, PhD⁷, Tontanai Numbenjapon, MD^8*, Kannadit Prayongratana, MD^8*, Tawatchai Suwanban, MD^9*, Suporn Chuncharunee, MD¹⁰, Pimjai Niparuck, MD^10*, Somchai Wongkhantee, MD^11*, Peerapon Wong, MD^12*, Nisa Makruasi, MD^13*, Nonglak Kanitsap, MD^14* and Tanin Intragumtornchai, MD, MSc⁵

¹Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand
²Department of Medicine, Chiang Mai University, Chiang Mai, Thailand
³Department of Internal Medicine, Prince of Songkla University, Songkla, Thailand
⁴Department of Medicine, Khon Kaen University, Khon Kaen, Thailand
⁵Department of Internal Medicine, Chulalongkorn University, Bangkok, Thailand
⁶Department of Medicine, Chulalongkorn University, Bangkok, Thailand
⁷Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
⁸Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
⁹Department of Medicine, Rajavithi Hospital, Bangkok, Thailand
¹⁰Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
¹¹Department of Medicine, Khonkaen Regional Hospital, Khon Kaen, Thailand
¹²Department of Medicine, Naresuan University, Phitsanulok, Thailand
¹³Department of Medicine, Srinakharinwirot University, Nakhon Nayok, Thailand
¹⁴Department of Medicine, Thammasat University, Bangkok, Thailand

Norina Tanaka, MD, PhD^*, Yoichi Imai, MD, PhD, Aya Watanabe, MD^*, Kenjiro Mitsuhashi, MD, PhD^*, Kentaro Yoshinaga, MD, PhD^*, Masayuki Shiseki, MD, PhD, Naoki Mori, MD, PhD^* and Junji Tanaka, M.D., Ph.D.

Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan

Won-Seog Kim, MD, PhD^1*, Michinori Ogura, MD, PhD^2,3, Toshiki Uchida, MD, PhD^3*, Naokuni Uike, M.D., Ph.D.^4,5*, Yasunobu Abe, MD, PhD^5*, Kenichi Ishizawa, M.D., Ph.D.^6,7*, Yoko Okitsu, MD, PhD^6*, Kensei Tobinai, MD, PhD⁸, Fumiko Nagahama^9*, Yusuke Sonehara^9* and Hirokazu Nagai, MD, PhD¹⁰

¹Department of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea
²Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan
³Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
⁴Department of Pallitive Care, Saga-ken Medical Center Koseikan, Saga, Japan
⁵Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
⁶Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan
⁷Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan
⁸National Cancer Center Hospital, Tokyo, Japan
⁹Development Division, Solasia Pharma K.K., Tokyo, Japan
¹⁰Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Tomohiro Kadota, MD^1,2*, Sachiko Seo, MD, Ph.D.², Yoshihiro Nakagami, MD^3*, Hiroe Fuse, MD^4*, Yujiro Ueda, MD^2*, Genichiro Ishii, MD, Ph.D.^5*, Kuniaki Itoh, MD^2*, Tomonori Yano, MD^1*, Kazuhiro Kaneko, MD, Ph.D^1* and Kunihiro Tsukasaki, M.D., Ph.D.²

¹Department of Gastroenterology, Endoscopy Division, National Cancer Center Hospital East, Chiba, Japan
²Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan
³Department of Diagnostic Radiology, National Cancer Center Hospital East, Chiba, Japan
⁴Department of Hematology, Matsudo city hospital, CHIBA, Japan
⁵Department of Pathology, National Cancer Center Hospital East, Chiba, Japan

Barbara Botto^1*, Federica Cavallo^2*, Manuela Zanni^3*, Antonella Anastasia^4*, Chiara Rusconi^5*, Annalisa Chiarenza^6*, Angela Ferrari^7*, Sara Rattotti^8*, Alessandra Dondi^9*, Marco Calabrese^10*, Andrea Evangelista^11*, Umberto Vitolo¹, Massimo Federico⁹ and Giuseppe Rossi, MD¹²

¹SC Ematologia, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
²Hematology Division, Department of Molecular Biothecnologies and Health Sciences, Torino, Italy
³Department of Translation Medicine- Amedeo Avogadro University of Eastern Piedmont, Hematology Division, Novara, Italy
⁴Hematology, Spedali Civili, Brescia, Italy
⁵Division of Hematology, Niguarda Ca' Granda Hospital, Milano, Italy
⁶Hematology Section, Department of Clinical and Molecular Biomedicine (MEDBIO), Catania, Italy
⁷Hematology Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy
⁸Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁹Oncologia Medica, Università di Modena e Reggio Emilia, Modena, Italy
¹⁰Fondazione Italiana Linfomi Onlus, Alessandria, Italy
¹¹Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
¹²Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

Jonathon B. Cohen, MD¹, Xuesong Han^2*, Xin Hu^3*, Ahmedin Jemal^2*, Elizabeth Ward^2* and Christopher Flowers, MD⁴

¹Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
²American Cancer Society, Atlanta, GA
³Rollins School of Public Health, Emory University, Atlanta, GA
⁴Winship Cancer Institute of Emory University, Atlanta, GA

Yuankai Shi, MD, PhD^1*, Bo Jia^1*, Xiaohui He, MD^1*, Youwu Shi^1*, Mei Dong, MD^1*, Jianliang Yang, MD^1*, Liqiang Zhou, MD^1*, Shengyu Zhou, MD^2*, Peng Liu, MD^2*, Yan Qin, MD^2*, Sheng Yang, MD^2*, Hua Lin, MD^3*, Lin Gui, MD^2*, Changgong Zhang, MD^2*, Lin Wang, MD^1*, Shanshan Chen, MD^1*, Puyuan Xing, MD^1*, Hongnan Mo, MD^1* and Mingzhe Han, M.D.⁴

¹Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China
²Department of Medical Oncology, Cancer Hospital and Institute,Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
³Department of Medical Record Library, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⁴Chinese Academy of Medical Sciences, Institute of Hematology, Tianjin, China

Sarit Assouline^1*, Michael Crump, MD², Torsten Holm Nielsen^1*, Miguel Alcaide, B. Sc., Ph. D.^3*, David Macdonald, MD, FRCPC⁴, Axel Tosikyan⁵, Tina Haliotis^1*, Celia Greenwood^1*, Kathleen Klein Oros^6*, Ryan Morin, PhD^3*, Nathalie Johnson, MD, PhD⁷ and Koren Kathleen Mann, PhD¹

¹McGill University, Montreal, QC, Canada
²Princess Margaret Hospital, Toronto, ON, Canada
³Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada
⁴QEII Health Sciences Centre, Halifax, NS, Canada
⁵Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada
⁶McGIll University, Montreal, QC, Canada
⁷Hematology, Jewish General Hospital, McGill University, Montreal, QC, Canada

Mitchell D.B. Hodgins, MD, FRCPC¹, Joy Mangel, MD, FRCPC², Gwynivere Davies, MD, FRCPC³, Leonard A. Minuk, MD, FRCPC⁴ and Selay Lam, BSc, MD, FRCPC⁵

¹University of Western Ontario, London, ON, Canada
²London Health Sciences Centre, London, ON, Canada
³University of Calgary In Canada, Calgary, AB, Canada
⁴London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada
⁵University of Western Ontario, London Health Sciences Centre, London, ON, Canada

Anna Nikonova, MD

Hematology/Oncology, McGill University, Montreal, QC, Canada

Marta García-Recio, MD^1*, Antonio Gutierrez, MD, PhD², Antonia Obrador-Hervia, PhD^3*, Lucia García Mañó, MD^2*, Leyre Bento, MD^1*, Juan Besalduch, MD, PhD¹, Jose Rodriguez, MD, PhD^4*, Antonia Sampol^2*, Priam Villalonga, PhD^3* and Silvia Fernandez, PhD^3*

¹Hospital Son Espases, Palma de Mallorca, Spain
²Hematology, Hospital Son Espases, Palma de Mallorca, Spain
³UIB, Hospital Son Espases, Palma de Mallorca, Spain
⁴Hematology, MD Anderson, Madrid, Spain

Alberto Pineda, MD^1*, Juan-Manuel Sancho, MD, PhD^1*, Olga Garcia, MD^1*, Jordi Esteve, MD, PhD², Mar Tormo, MD, PhD³, Pilar Martinez, MD^4*, Ferran Vall-llovera, MD^5*, Rodrigo Martino, MD, PhD⁶, Pau Montesinos, MD^7*, Jose Gonzalez-Campos, MD^8*, Juan Bergua^9*, María Calbacho, MD^10*, Cristina Gil, MD^11*, Ana Vicent, MD^12*, Antònia Cladera, MD^13*, Jesus Hernandez, MD^14*, Maria-José Moreno, MD^15*, Alfons Serrano, MD^16*, Natalia Alonso, MD^17*, Raimundo García, MD^18*, Pere Barba, MD, PhD^19*, Angeles Fernandez, MD^20*, Pilar Miralles, MD, PhD^21*, Andrés Novo, MD^22*, Jose Maria Moraleda, MD, PhD^23*, José Ángel Hernández, MD^24*, Eugenia Abella, MD, PhD^25*, Magdalena Sanchez, MD^26*, Maria-Elsa Lopez, MD^27*, Teresa Bernal, MD^28*, Mª Carmen Mateos, MD^29*, Esperanza Lavilla, MD^30* and Josep-Maria Ribera, MD, PhD¹

¹Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
²Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
³Hospital Clínico Universitario de Valencia, Valencia, Spain
⁴Hospital Universitario Doce de Octubre, Madrid, Spain
⁵Hospital Universitari Mutua Terrassa, Terrassa, Spain
⁶Hospital Santa Creu i Sant Pau, Barcelona, Spain
⁷Hematology, Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain
⁸Hospital Universitario Virgen del Rocío, Sevilla, Spain
⁹Hospital San Pedro de Alcántara, Cáceres, Spain
¹⁰Hospital Universitario Ramon y Cajal, Madrid, Spain
¹¹Hospital General de Alicante, Alicante, Spain
¹²ICO-Hospital Joan XXIII, Tarragona, Spain
¹³Hospital Son Llàtzer, Palma de Mallorca, Spain
¹⁴Hospital Universitario de Salamanca, Salamanca, Spain
¹⁵Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
¹⁶Hospital Madrid Sanchinarro, Madrid, Spain
¹⁷Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
¹⁸Hospital General Universitario de Castellón, Castellón, Spain
¹⁹Department of Hematology, Hospital Vall d'Hebron, Barcelona, Spain
²⁰Hospital Xeral Cíes, Vigo, Spain
²¹Hospital Gregorio Marañón, Madrid, Spain
²²Hospital Son Espases, Palma de Mallorca, Spain
²³Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
²⁴Department of Hematology, Hospital Universitario Infanta Leonor, Madrid, Spain
²⁵Hospital del Mar, Barcelona, Spain
²⁶Hospital General Universitario, Valencia, Valencia, Spain
²⁷Hospital Clínico Universitario Ourense, Ourense, Spain
²⁸Hospital Universitario Central de Asturias, Oviedo, Spain
²⁹Hospital Virgen del Camino, Pamplona, Spain
³⁰Hospital Lucus Augusti, Lugo, Spain